Results 101 to 110 of about 256,609 (339)

Left ventricular reverse remodelling predicts long‐term outcomes in patients with functional mitral regurgitation undergoing MitraClip therapy: results from a multicentre registry

open access: yesEuropean Journal of Heart Failure, 2018
To explore whether left ventricular reverse remodelling (LVRR) is a predictor of outcomes in patients with functional mitral regurgitation (FMR) undergoing MitraClip procedure.
M. Adamo   +19 more
semanticscholar   +1 more source

Atrial cardiomyopathy

open access: yes
ESC Heart Failure, Volume 12, Issue 2, Page 727-729, April 2025.
Wojciech Kosmala   +1 more
wiley   +1 more source

Employment of artificial intelligence for an unbiased evaluation regarding the recovery of right ventricular function after mitral valve transcatheter edge‐to‐edge repair

open access: yesEuropean Journal of Heart Failure, EarlyView.
Impact of mitral transcatheter edge‐to‐edge repair (M‐TEER) on left and right heart function. IQR, interquartile range; LA, left atrial; RVEF, right ventricular ejection fraction; sPAP, systolic pulmonary artery pressure; TAPSE, tricuspid annular plane systolic excursion. Abstract Aims Long‐standing severe mitral regurgitation (MR) leads to left atrial
Vera Fortmeier   +21 more
wiley   +1 more source

Cardiac resynchronization therapy for enabling guideline‐directed medical therapy optimization in heart failure

open access: yesEuropean Journal of Heart Failure, EarlyView.
Cardiac resynchronization therapy (CRT) as an enabler for guideline‐directed medical therapy (GDMT) in the Swedish Heart Failure Registry (SwedeHF). The figure summarizes the selection of the study population, changes in GDMTs and loop diuretic use/doses from baseline to 1.5‐year follow‐up in patients receiving versus not receiving CRT, and reports the
Daniela Tomasoni   +17 more
wiley   +1 more source

Towards comprehensive assessment of mitral regurgitation using cardiovascular magnetic resonance

open access: yesJournal of Cardiovascular Magnetic Resonance, 2008
Cardiovascular magnetic resonance (CMR) is increasingly used to assess patients with mitral regurgitation. Its advantages include quantitative determination of ventricular volumes and function and the mitral regurgitant fraction, and in ischemic mitral ...
Firmin David N   +8 more
doaj   +1 more source

Liver stiffness measurement for non‐invasive assessment of central venous pressure in patients with heart failure: A multicentre pilot study

open access: yesEuropean Journal of Heart Failure, EarlyView.
Liver stiffness measurement for central venous pressure assessment. AUC, area under the curve; BMI, body mass index; CI, confidence interval; CVP, central venous pressure; HF, heart failure; LSM, liver stiffness measurement; LVEF, left ventricular ejection fraction. Abstract Aims Central venous pressure (CVP) is an important variable in assessing heart
Nicolas Girerd   +16 more
wiley   +1 more source

Novel mutation associated with non‐compaction ventricular myocardium: A case report

open access: yes
ESC Heart Failure, EarlyView.
Yan Li   +4 more
wiley   +1 more source

Prognostic value of NT‐proBNP in patients with primary mitral regurgitation undergoing transcatheter edge‐to‐edge repair

open access: yesEuropean Journal of Heart Failure, EarlyView.
In the PRIME‐MR study, patients with higher N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP) tertiles more frequently reached death or heart failure hospitalization (HFH) within 3 years. Log‐transformed NT‐proBNP levels independently predicted the primary endpoint (adjusted hazard ratio 1.17, 95% confidence interval 1.07–1.28; p < 0.001).
Philipp von Stein   +70 more
wiley   +1 more source

Home - About - Disclaimer - Privacy